Multiple long-term conditions: multimorbidity register
Indicator
The practice can produce a register of people with multimorbidity who would benefit from a tailored approach to care.
Indicator type
General practice indicator suitable for use in the Quality and Outcomes Framework.
This document does not represent formal NICE guidance. For a full list of NICE indicators, see our menu of indicators.
To find out how to use indicators and how we develop them, see our NICE indicator process guide.
Rationale
Multimorbidity is associated with reduced quality of life, higher mortality, polypharmacy and higher treatment burden, higher rates of adverse drug events and greater use of health services including unplanned admissions and emergency care.
The register will support interventions that lead to improvement in health-related quality of life, care related decisions and patient safety and reduce adverse outcomes such as unplanned admissions. The indicator is also a measure of case-mix and potentially workload in general practice.
Development
The NICE guideline on multimorbidity defines multimorbidity as the presence of 2 or more long-term health conditions. The NICE indicator advisory committee originally explored creating a register based on presence on 2 or more 'QOF registers', however this limited the number of conditions significantly. It also resulted in a register of people who were likely already under regular review.
Bespoke analysis undertaken by the North East Quality Observatory Service for the NICE indicator advisory committee in a sample of 14 practices using a an adapted list of 30 conditions from the SPIRE project found that when developed into a systematic search of practice data, the number of people with two or more long term conditions was a substantial proportion of practice lists. Publications analysing general practice data (Barnett et al. 2012, Cassell et al. 2018, and Health Foundation, 2018) also found similar results.
Number of conditions | Barnet et al. 2012 | Health Foundation 2018 | Cassell et al. 2018 | NEQOS analysis SPIRE30 | NEQOS analysis SPIRE30 |
---|---|---|---|---|---|
0 |
57.8% |
54.0% |
- |
43.6% |
43.6% |
1+ |
42.1% |
46.0% |
- |
56.4% |
56.4% |
2+ |
23.1% |
24.0% |
27.2% |
28.1% |
25.8% |
3+ |
13.5% |
13.8% |
- |
13.8% |
10.3% |
4+ |
7.8% |
7.7% |
- |
6.8% |
3.5% |
5+ |
1.2% |
- |
- |
3.2% |
0.96% |
6+ |
2.4% |
- |
- |
1.5% |
0.19% |
This NICE indicator uses the presence of 4 or more condition clusters as a pragmatic definition of severe multimorbidity that balances clinical validity with the size of the population identified. It reflects an appraisal of international evidence, analysis of primary care data, and discussions with national academic, GP and clinical leads alongside the NICE Indicator Advisory Committee to agree an acceptable and practical population size on which to focus subsequent interventions. The indicator makes use of existing data to allow the register of people with multiple conditions to be constructed.
Cluster | Condition |
---|---|
Cancer |
Cancer |
Chronic pain |
Painful condition (4 or more prescription only medicine analgesic prescriptions or 4 or more specified anti-epileptics in the absence of an epilepsy Read code in last 12 months) |
Circulatory conditions |
|
Diabetes |
Diabetes |
Digestive system conditions |
|
Learning disability |
Learning disability |
Mental health |
|
Musculoskeletal conditions |
|
Neurological conditions |
|
Renal conditions |
Chronic kidney disease |
Respiratory conditions |
|
Source guidance
Multimorbidity: clinical assessment and management. NICE guideline NG56 (2016), recommendations 1.1.1 and 1.3.1
Specification
A register of people with 4 or more condition clusters or a determination what they would benefit from a tailored approach to care.
Exclusions: People under 18 years.
ISBN: 978-1-4731-5959-4